Thermo Fisher Scientific Inc (NYSE:TMO) under-valued by 11%
| Website | https://www.thermofisher.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $179,582,353,408 |
| Beta | 0.759893 |
| Average Volume | $1,761,442 |
| Last Dividend | 0.92% |
| Price on May 7, 2021 | $456.92 |
| Autochartist™ Valuation | $507.59 |
| Conclusion |
11% under-valued |
| Download Report |
